FDA advisors unanimously recommend approval of Eli Lilly’s Alzheimer’s drug donanemab. The Biden administration proposes a rule to ban medical debt from consumer credit reports. And the U.S. Supreme Court will review a case on Medicare Disproportionate Share Hospital payments. That’s coming up on today’s episode of Gist Healthcare Daily.
","author_name":"Gist Healthcare Daily"}